NCT03669458View on ClinicalTrials.gov

Feasibility Clinical Trial Using the SPUR System to Demonstrate Safety and Efficacy.

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

October 6, 2017

Primary Completion Date

June 4, 2019

Study Completion Date

June 4, 2019

Conditions
Critical Limb Ischemia
Interventions
DEVICE

Below the Knee peripheral intervention

Treatment of infrapopliteal disease using SPUR/DCB, SPUR only and DCB alone

Trial Locations (1)

Unknown

Instituto Nacional de la Diabetes (INDEN), Santo Domingo

All Listed Sponsors
collaborator

Syntropic Corelab

UNKNOWN

collaborator

Massachusetts General Hospital

OTHER

lead

ReFlow Medical, Inc.

INDUSTRY

NCT03669458 - Feasibility Clinical Trial Using the SPUR System to Demonstrate Safety and Efficacy. | Biotech Hunter | Biotech Hunter